15-year-old Mia Campos, a skilled gymnast from San Antonio, has been living with type 1 diabetes for five years. She was diagnosed during a gymnastics competition when she began experiencing symptoms like excessive thirst and frequent urination. Mia was fitted with a traditional insulin pump which required constant programming and often experienced glitches. However, her pediatric endocrinologist recommended the “bionic pancreas,” which has now been cleared by the FDA for commercial use.
The iLet device is clipped to her jeans and uses AI software to tailor insulin delivery to her glucose levels. The device requires just one input regarding the size of the user’s next meal. It then learns the user’s biorhythms and delivers insulin accordingly, keeping blood sugar levels stable. Mia is thrilled with the benefits of the device, allowing her to focus on her homework and gymnastics training rather than constantly worrying about her carb intake and insulin levels.
Mia believes that this new technology will greatly benefit individuals, particularly children, who have busy lives and struggle to manually track their carb intake. Dr. Lynch, Mia’s pediatric endocrinologist, emphasizes that diet and exercise are still critical components of managing blood sugar levels. The “bionic pancreas” uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed.
The FDA recently approved a revolutionary device called the “bionic pancreas” for diabetics that can help take the burden off users of continually entering carb intake. The iLet device allows users to simply input the size of their next meal, and an AI algorithm determines the precise amount of insulin needed to keep blood sugar stable.
The approval of this device has been life-changing for Mia Campos who has been living with type 1 diabetes for five years. She was diagnosed during a gymnastics competition when she began experiencing symptoms like excessive thirst and frequent urination.
Mia was fitted with a traditional insulin pump which required constant programming and often experienced glitches. However, her pediatric endocrinologist recommended the “bionic pancreas,” which has now been cleared by the FDA for commercial use.
The iLet device requires just one input regarding the size of the user’s next meal, making it easy for users to manage their blood sugar levels without having to constantly worry about it.
Dr. Lynch emphasizes that diet and exercise are still critical components of managing blood sugar levels but believes that this new technology will greatly benefit individuals, particularly children who have busy lives and struggle to manually track their carb intake.
The “bionic pancreas” uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed.
